Single-cell RNA sequencing (scRNA-seq) is an evolving technology used to elucidate the cellular architecture of adult organs. Previous scRNA-seq on breast tissue utilized reduction mammoplasty samples, which are often histologically abnormal. We report a rapid tissue collection/processing protocol to perform scRNA-seq of breast biopsies of healthy women and identify 23 breast epithelial cell clusters. Putative cell-of-origin signatures derived from these clusters are applied to analyze transcriptomes of ~3,000 breast cancers. Gene signatures derived from mature luminal cell clusters are enriched in ~68% of breast cancers, whereas a signature from a luminal progenitor cluster is enriched in ~20% of breast cancers. Overexpression of luminal p...
Background: The invention and development of single-cell technologies have contributed a lot to the ...
Background: The invention and development of single-cell technologies have contributed a lot to the ...
There is a need to individualize assays for tumor molecular phenotyping, given variations in the dif...
INTRODUCTION: Diverse microarray and sequencing technologies have been widely used to characterise t...
BACKGROUND: Increased understanding of the variability in normal breast biology will enable us to id...
Breast cancer arises from breast epithelial cells that acquire genetic alterations leading to subseq...
Breast cancer arises from breast epithelial cells that acquire genetic alterations leading to subseq...
SummaryThe identification of breast cancer cell subpopulations featuring truly malignant stem cell q...
The identification and molecular characterization of cellular hierarchies in complex tissues is key ...
Cell-type origin is one of the factors that determine molecular features of tumors, but resources to...
Single-cell analysis has revolutionised genomic science in recent years. However, due to cost and ot...
Breast cancer tumors display different cellular phenotypes. A growing body of evidence points toward...
We analysed primary breast cancers by genomic DNA copy number arrays, DNA methylation, exome sequenc...
The breast is a dynamic organ whose response to physiological and pathophysiological conditions alte...
Background - Several evidences support the presence of a subpopulation of tumorpromoting cells (TPCs...
Background: The invention and development of single-cell technologies have contributed a lot to the ...
Background: The invention and development of single-cell technologies have contributed a lot to the ...
There is a need to individualize assays for tumor molecular phenotyping, given variations in the dif...
INTRODUCTION: Diverse microarray and sequencing technologies have been widely used to characterise t...
BACKGROUND: Increased understanding of the variability in normal breast biology will enable us to id...
Breast cancer arises from breast epithelial cells that acquire genetic alterations leading to subseq...
Breast cancer arises from breast epithelial cells that acquire genetic alterations leading to subseq...
SummaryThe identification of breast cancer cell subpopulations featuring truly malignant stem cell q...
The identification and molecular characterization of cellular hierarchies in complex tissues is key ...
Cell-type origin is one of the factors that determine molecular features of tumors, but resources to...
Single-cell analysis has revolutionised genomic science in recent years. However, due to cost and ot...
Breast cancer tumors display different cellular phenotypes. A growing body of evidence points toward...
We analysed primary breast cancers by genomic DNA copy number arrays, DNA methylation, exome sequenc...
The breast is a dynamic organ whose response to physiological and pathophysiological conditions alte...
Background - Several evidences support the presence of a subpopulation of tumorpromoting cells (TPCs...
Background: The invention and development of single-cell technologies have contributed a lot to the ...
Background: The invention and development of single-cell technologies have contributed a lot to the ...
There is a need to individualize assays for tumor molecular phenotyping, given variations in the dif...